Fulcrum Therapeutics, Inc.’s (FULC) CEO Bryan Stuart on Q4 2021 results – Call Transcript
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2021 Earnings Conference Call March 3, 2022 8:00 AM ET Company Participants Christi Waarich – Director of Investor Relations Bryan Stuart – President and Chief Executive Officer Judy Dunn – […]
